Treatment of the chronic fatigue syndrome. A review and practical guide.
Blondel-Hill, E, Shafran, S D · Drugs · 1993 · DOI
Quick Summary
This 1993 guide explains that ME/CFS is a real illness defined by severe, disabling fatigue along with other physical and mental symptoms, though its exact cause remains unknown. The main treatment is getting a proper diagnosis, learning about the condition, and working with a caring doctor who understands it. Some patients may benefit from antidepressant medications even without depression, though no single treatment has been proven to work reliably for everyone.
Why It Matters
This guideline addresses a critical gap in CFS management by emphasizing diagnostic clarity and the therapeutic value of empathetic clinical engagement in reducing unnecessary investigation and specialist referrals. It highlights that despite decades of research, no single disease mechanism explains CFS and no proven pharmacological cure exists, underscoring the need for individualized symptom-based approaches.
Observed Findings
Immune function and neuroimaging abnormalities have been reported in variable subsets of CFS patients but findings are inconsistent across studies
Diagnosis currently relies on the 1992 CDC case definition, which remains controversial due to subjective elements
Antidepressants are commonly prescribed to CFS patients even without major depression diagnosis
Many treatments have been reported anecdotally to be beneficial but lack reproducible evidence from rigorous trials
Patient education and empathetic clinical engagement can reduce excessive specialist referrals and unnecessary investigations
Inferred Conclusions
The diagnosis and education provided by an empathetic clinician are themselves therapeutic interventions that address harmful patterns of behavior (doctor shopping, over-investigation)
Antidepressant selection should be tailored to individual symptom profiles (e.g., targeting insomnia vs. hypersomnia) rather than treating presumed depression
The lack of proven disease-specific treatments means current management must be symptomatic and individualized
Improved case definitions and larger, well-controlled treatment trials are needed to advance CFS therapeutics
Remaining Questions
What This Study Does Not Prove
This review does not establish the underlying biological cause of ME/CFS, nor does it prove that antidepressants or any other specific medication is effective for the majority of patients. The guideline acknowledges that most proposed treatments lack robust double-blind, placebo-controlled evidence and cannot be recommended as established therapies.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →